Lantern Pharma Inc. Common Stock (LTRN) is a publicly traded Healthcare sector company. As of August 24, 2026, LTRN trades at $2.29 with a market cap of $29.91M and a P/E ratio of -1.51. LTRN moved -1.97% today. Year to date, LTRN is -22.77%; over the trailing twelve months it is -44.15%. Its 52-week range spans $1.11 to $6.12. Rallies surfaces LTRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LTRN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.29 |
| Market Cap | $29.91M |
| P/E Ratio | -1.51 |
| EPS | $-1.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.12 |
| 52-Week Low | $1.11 |
| Volume | 585 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-17.12M |
| Gross Margin | 0.00% |
LTRN analyst coverage data. Average price target: $0.00.